Skip to main content
. 2021 Nov 8;13:759182. doi: 10.3389/fnagi.2021.759182

TABLE 1.

Clinical characteristics of the patients with Parkinson’s disease (PD) and healthy controls (HC).

HC (n = 40) PD
Early (n = 24) Advanced (n = 18) Total (n = 42)
Sex (female/male) 19/21 9/15 8/10 17/25
Age (years) 65.85 ± 7.52 61.58 ± 9.57 71.61 ± 9.15 65.88 ± 10.55
Duration (years) 5.78 ± 4.94 13.06 ± 6.58 8.88 ± 6.69
Hoehn and Yahr stage 1.54 ± 0.51 3.22 ± 0.43 2.17 ± 0.93
LEDD (mg) 549.73 ± 548.88 1422.69 ± 662.50 923.86 ± 736.32
UPDRS-total 23.38 ± 6.53 69.29 ± 21.71 42.37 ± 27.15
UPDRS-part III 13.92 ± 5.40 40.36 ± 12.54 24.88 ± 15.93
MMSE 29.62 ± 0.72 28.33 ± 2.76 22.59 ± 6.48 25.95 ± 5.42
CDR 0.13 ± 0.22 0.27 ± 0.25 0.59 ± 0.40 0.41 ± 0.36